The FDA grants de novo clearance to HeartFlow's novel system for non-invasive measurement of fractional flow reserve, which CEO Dr. John Stevens calls "the gold standard" for diagnosing and treating coronary disease.
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
The Obama administration wants to change the way Medicare reimburses doctors, moving from a fee-for-service model to alternative payment models emphasizing cost containment and quality of care.
(Reuters) — The Obama administration today unveiled an ambitious plan to control health costs by moving the $2.9 trillion U.S. healthcare systems away from costly fee-for-service medicine, beginning with the Medicare program for the elderly and disabled.